Genetown
Filter News
Found 54,917 articles
-
Over the course of 2018, the FDA approved 59 different novel drugs that range for the treatment of various cancers, chronic obstructive pulmonary disease (COPD), traveler’s diarrhea, migraine headaches and more.
-
New Year, fresh start? Could be. WalletHub recently compared more than 180 cities across the U.S., using 30 key indicators to evaluate their job strength. Some of those factors were job opportunities, employment growth, monthly average starting salary and employment outlook.
-
Your Feedback Matters! Topics in 2019
1/15/2019
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. Let us know which topics you want to hear more about. -
Boston Grants Ascend Massachusetts Approval to Open the First Adult-Use Cannabis Retail Store
1/15/2019
Ascend Massachusetts, a wholly owned subsidiary of Ascend Wellness Holdings (AWH), announced today that it was awarded the first conditional-use permit for adult-use cannabis retail sales in the city of Boston.
-
MilliporeSigma Wins Life Science Industry Award® for Best Use of Social Media
1/15/2019
MilliporeSigma today announced that it has been recognized by BioInformatics LLCwith a 2018 Life Science Industry Award® for best use of social media.
-
Life Biosciences Announces Closing Of $50 Million Series B Financing Round
1/15/2019
Life Biosciences has announced the closing of a Series B financing round of $50 million, according to Tristan Edwards, chief executive officer and co-founder. T
-
AllCare Plus Pharmacy Introduces Renamed Business Divisions--Access Services and Hospital Solutions--As Part of Strategic Reorganization
1/15/2019
AllCare Plus Pharmacy, New England's largest independent specialty pharmacy, today announced the renaming of its two business divisions: AllCare Access Services and AllCare Hospital Solutions.
-
2019 Best Wellness Employer Certification Survey Open for Employers
1/15/2019
Wellness Workdays, a leader in corporate wellness programs, announces the survey for the 2019 Best Wellness Employer certification program is open.
-
Waters Accelerates Biomedical Research with Faster, More Accurate Amino Acid Analysis
1/15/2019
Kairos Amino Acid Analysis Kit Simplifies and Automates LC/MS-MS Quantification of Amino Acids in Human Plasma and Urine
-
RadMD and AG Mednet Launch Collect and Hold Service with Real-Time Medical Image Accessibility
1/15/2019
RadMD, an expert-based Management Services Organization focused on imaging in clinical trials, has signed a partnership agreement with AG Mednet to use Judi // Imaging to manage site reads and "Collect and Hold" image operations in support of global clinical trials across all therapeutic areas.
-
Ironwood Pharmaceuticals Announces Approval of LINZESS® (linaclotide) in China for the Treatment of Adults with IBS-C
1/15/2019
Ironwood anticipates that it will launch the drug with its partner in China, AstraZeneca, in the second half of 2019.
-
At a Cost of $10,405 Per Patient Stay, Hypoglycemia in The Hospital Cannot Be Ignored
1/15/2019
A diabetes webinar hosted by the American Hospital Association and sponsored by Glytec showcased why hypoglycemia prevention is imperative to the safety of patients and to the economics of healthcare delivery.
-
Seres Therapeutics Announces Chief Executive Officer Transition
1/15/2019
Eric Shaff, previously Chief Operating and Financial Officer, appointed President and Chief Executive Officer
-
Aldeyra Therapeutics Announces Promotion of Stephen G. Machatha, Ph.D. to Position of Senior Vice President of Technical Operations
1/15/2019
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to inventing, developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that Stephen G. Machatha, Ph.D. has been promoted to the position of Senior Vice President,
-
MEDITECH Furthers Commitment to Interoperability as Northwestern Medical Center Goes Live with CommonWell Services
1/15/2019
Leading EHR vendor strengthens CommonWell footprint as Vermont health system deploys services, advancing interoperability initiatives
-
Orbita Expedites Conversational AI Development With No-Code Prototyping For Voice And Chat Bot Applications
1/15/2019
Orbita, Inc., which provides the only enterprise-grade platform for powering secure voice and chatbot applications in healthcare, today unveils a new tool that enables designers to quickly develop a "rough draft" conversational dialogue and then make it available to key stakeholders for testing, measurement, and iteration
-
Alnylam Pharmaceuticals Prices Public Offering of Common Stock - January 15, 2019
1/15/2019
Alnylam Pharmaceuticals, the leading RNAi therapeutics company, announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $77.50 per share.
-
Boston Scientific, Edwards Lifesciences Agree To Global Litigation Settlement
1/15/2019
All Patent Litigation Between the Companies to be Dismissed
-
CutisPharma Announces New Management Team Appointments
1/15/2019
Mike Radice named as Chief Commercial Officer, current Chief Financial Officer Ron Scarboro will also assume role of Chief Operating Officer and Hanok George named as General Counsel
-
Blue Cross Blue Shield Of Massachusetts Provides $1M In Grants To Fund Recovery Coaches
1/15/2019
Insurer continues opioids leadership by supporting growth and development of recovery coach workforce